Levic Katarina, Bulut Orhan, Hesselfeldt Peter, Bülow Steffen
Gastroenheden, Kirurgisk Sektion, Hvidovre Hospital, Kettegaard Allé 30, 2650 Hvidovre, Denmark.
Dan Med J. 2012 Sep;59(9):A4507.
Transanal endoscopic microsurgery (TEM) allows locally complete resection of early rectal cancer as an alternative to conventional radical surgery. In patients with unfavourable post-TEM histology, salvage surgery can be performed. The aim of this study was to evaluate the results of early radical surgery after TEM for rectal cancer.
From 1997 to 2010, 86 TEM procedures were performed in 79 patients due to rectal cancer. Early salvage surgery was performed in 25 patients. Data were obtained from the patients' charts and reviewed retrospectively. Perioperative data and oncological outcome were analysed.
No patients received preoperative chemotherapy. The median time to salvage surgery was 37 days. Five patients underwent laparoscopic surgery. The median operative time was 165 min (range: 101-341 min, 95% confidence interval (CI): 156-214 min) and the median blood loss 275 ml (range: 0-1,275 ml, 95% CI: 232-530 ml). The 30-day mortality was 8% (95% CI: 1-19%, n = 2). Intraoperative perforation occurred in 20% (95% CI: 3-37%, n = 5). The median number of harvested lymph nodes was 12 (range: 3-25, 95% CI: 9-14) and the median circumferential resection margin (CRM) was 10 mm (range: 0-20 mm, 95% CI: 5-12 mm). Only one patient (4%, 95%CI: 1-12%) had a positive CRM. The median follow-up time was 25 months (range: 3-80 months). There was no local recurrence. Distant metastasis occurred in 4% (95% CI: 1-12%, n = 1).
Early salvage surgery after TEM seems to be safe despite a high risk of specimen perforation during the operation.
not relevant.
not relevant.
经肛门内镜显微手术(TEM)可对早期直肠癌进行局部完整切除,作为传统根治性手术的替代方案。对于TEM术后组织学结果不理想的患者,可进行挽救性手术。本研究旨在评估直肠癌TEM术后早期根治性手术的结果。
1997年至2010年,79例患者因直肠癌接受了86次TEM手术。25例患者接受了早期挽救性手术。数据取自患者病历并进行回顾性分析。分析围手术期数据和肿瘤学结局。
无患者接受术前化疗。挽救性手术的中位时间为37天。5例患者接受了腹腔镜手术。中位手术时间为165分钟(范围:101 - 341分钟,95%置信区间(CI):156 - 214分钟),中位失血量为275毫升(范围:0 - 1275毫升,95% CI:232 - 530毫升)。30天死亡率为8%(95% CI:1 - 19%,n = 2)。术中穿孔发生率为20%(95% CI:3 - 37%,n = 5)。中位清扫淋巴结数为12个(范围:3 - 25个,95% CI:9 - 14个),中位环周切缘(CRM)为10毫米(范围:0 - 20毫米,95% CI:5 - 12毫米)。仅1例患者(4%,95% CI:1 - 12%)CRM阳性。中位随访时间为25个月(范围:3 - 80个月)。无局部复发。远处转移发生率为4%(95% CI:1 - 12%,n = 1)。
尽管手术中标本穿孔风险较高,但TEM术后早期挽救性手术似乎是安全的。
不相关。
不相关。